Report Detail
Global mRNA Vaccine Core Enzyme Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4532019 |
- 15 October, 2023 |
- Global |
- 104 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global mRNA Vaccine Core Enzyme market size was valued at USD 3965.6 million in 2022 and is forecast to a readjusted size of USD 3349.5 million by 2029 with a CAGR of -2.4% during review period.
mRNA-vaccines can efficiently activate both components of the immune system, i.e., T-cell and humoral responses. The essential advantage of mRNA vaccines includes fast, inexpensive, scalable and uniform production providing a large output of desirable products in vitro. Synthesis and purification processes significantly simplify the process technology of mRNA drugs with injectable purity. Thus, mRNA production via in vitro transcription is more advantageous as compared with DNA-vaccines since it is a chemical process without the use of cells. mRNA techniques make it possible to pass all the phases of vaccine development much faster in comparison with the production of vaccines based on inactivated viruses or recombinant proteins. This property is critically important when designing vaccines against viral pathogens as the main problem of disease control includes a time gap between an epidemic and vaccine development.
mRNA vaccine core enzyme is the key raw material in the production of mRNA vaccine and drugs. In this report, mRNA vaccine core enzyme includes RNA Polymerase, Capping Enzyme, 2'-O-Methyltransferase, Inorganic Pyrophosphatase, Poly (A) Polymerase, RNase Inhibitor, RNA Polymerase, Restriction Enzyme, DNase I, etc.
mR
In the global market, the key players of mRNA Vaccine Core Enzyme are mainly Thermo Fisher, NEB, TriLink Bio Technologies, Merck, ect. The top three players within this industry hold about 40% of the market share. North America, Europe, and Asia-Pacific are the major manufacturing regions for this product, with North America accounting for about 38% of the global market share. The product can be classified on the basis of enzyme type into capsidases, 2′O-methyltransferases, inorganic pyrophosphatases, poly(A) polymerases, ribonuclease inhibitors, RNA polymerases, restriction endonucleases, deoxyribonucleases I, and other enzymes. These products are widely used by biopharmaceutical companies, academic and research institutions.
The Global Info Research report includes an overview of the development of the mRNA Vaccine Core Enzyme industry chain, the market status of Biopharmaceutical Companies (Capping Enzyme, 2'-O-Methyltransferase), Academic and Research Institutes (Capping Enzyme, 2'-O-Methyltransferase), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of mRNA Vaccine Core Enzyme.
Regionally, the report analyzes the mRNA Vaccine Core Enzyme markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global mRNA Vaccine Core Enzyme market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the mRNA Vaccine Core Enzyme market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the mRNA Vaccine Core Enzyme industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Enzyme Type (e.g., Capping Enzyme, 2'-O-Methyltransferase).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the mRNA Vaccine Core Enzyme market.
Regional Analysis: The report involves examining the mRNA Vaccine Core Enzyme market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the mRNA Vaccine Core Enzyme market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to mRNA Vaccine Core Enzyme:
Company Analysis: Report covers individual mRNA Vaccine Core Enzyme players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards mRNA Vaccine Core Enzyme This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Biopharmaceutical Companies, Academic and Research Institutes).
Technology Analysis: Report covers specific technologies relevant to mRNA Vaccine Core Enzyme. It assesses the current state, advancements, and potential future developments in mRNA Vaccine Core Enzyme areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the mRNA Vaccine Core Enzyme market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
mRNA Vaccine Core Enzyme market is split by Enzyme Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Enzyme Type, and by Application in terms of value.
Market segment by Enzyme Type
Capping Enzyme
2'-O-Methyltransferase
Inorganic Pyrophosphatase
Poly (A) Polymerase
Rnase Inhibitor
RNA Polymerase
Restriction Enzyme
Dnase I
Others
Market segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
Market segment by players, this report covers
Thermo Fisher
NEB
TriLink Bio Technologies
Merck
Aldevron
Qiagen N.V.
Promega
Roche CustomBiotech
Takara Bio Inc.
Novoprotein
Vazyme
Hongene Biotech Corporatio
Yeasen Biotechnology
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe mRNA Vaccine Core Enzyme product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of mRNA Vaccine Core Enzyme, with revenue, gross margin and global market share of mRNA Vaccine Core Enzyme from 2018 to 2023.
Chapter 3, the mRNA Vaccine Core Enzyme competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Enzyme Type and application, with consumption value and growth rate by Enzyme Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and mRNA Vaccine Core Enzyme market forecast, by regions, enzyme type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of mRNA Vaccine Core Enzyme.
Chapter 13, to describe mRNA Vaccine Core Enzyme research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of mRNA Vaccine Core Enzyme
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of mRNA Vaccine Core Enzyme by Enzyme Type
- 1.3.1 Overview: Global mRNA Vaccine Core Enzyme Market Size by Enzyme Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global mRNA Vaccine Core Enzyme Consumption Value Market Share by Enzyme Type in 2022
- 1.3.3 Capping Enzyme
- 1.3.4 2'-O-Methyltransferase
- 1.3.5 Inorganic Pyrophosphatase
- 1.3.6 Poly (A) Polymerase
- 1.3.7 Rnase Inhibitor
- 1.3.8 RNA Polymerase
- 1.3.9 Restriction Enzyme
- 1.3.10 Dnase I
- 1.3.11 Others
- 1.4 Global mRNA Vaccine Core Enzyme Market by Application
- 1.4.1 Overview: Global mRNA Vaccine Core Enzyme Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Biopharmaceutical Companies
- 1.4.3 Academic and Research Institutes
- 1.5 Global mRNA Vaccine Core Enzyme Market Size & Forecast
- 1.6 Global mRNA Vaccine Core Enzyme Market Size and Forecast by Region
- 1.6.1 Global mRNA Vaccine Core Enzyme Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global mRNA Vaccine Core Enzyme Market Size by Region, (2018-2029)
- 1.6.3 North America mRNA Vaccine Core Enzyme Market Size and Prospect (2018-2029)
- 1.6.4 Europe mRNA Vaccine Core Enzyme Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific mRNA Vaccine Core Enzyme Market Size and Prospect (2018-2029)
- 1.6.6 South America mRNA Vaccine Core Enzyme Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa mRNA Vaccine Core Enzyme Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 Thermo Fisher
- 2.1.1 Thermo Fisher Details
- 2.1.2 Thermo Fisher Major Business
- 2.1.3 Thermo Fisher mRNA Vaccine Core Enzyme Product and Solutions
- 2.1.4 Thermo Fisher mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Thermo Fisher Recent Developments and Future Plans
- 2.2 NEB
- 2.2.1 NEB Details
- 2.2.2 NEB Major Business
- 2.2.3 NEB mRNA Vaccine Core Enzyme Product and Solutions
- 2.2.4 NEB mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 NEB Recent Developments and Future Plans
- 2.3 TriLink Bio Technologies
- 2.3.1 TriLink Bio Technologies Details
- 2.3.2 TriLink Bio Technologies Major Business
- 2.3.3 TriLink Bio Technologies mRNA Vaccine Core Enzyme Product and Solutions
- 2.3.4 TriLink Bio Technologies mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 TriLink Bio Technologies Recent Developments and Future Plans
- 2.4 Merck
- 2.4.1 Merck Details
- 2.4.2 Merck Major Business
- 2.4.3 Merck mRNA Vaccine Core Enzyme Product and Solutions
- 2.4.4 Merck mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Merck Recent Developments and Future Plans
- 2.5 Aldevron
- 2.5.1 Aldevron Details
- 2.5.2 Aldevron Major Business
- 2.5.3 Aldevron mRNA Vaccine Core Enzyme Product and Solutions
- 2.5.4 Aldevron mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Aldevron Recent Developments and Future Plans
- 2.6 Qiagen N.V.
- 2.6.1 Qiagen N.V. Details
- 2.6.2 Qiagen N.V. Major Business
- 2.6.3 Qiagen N.V. mRNA Vaccine Core Enzyme Product and Solutions
- 2.6.4 Qiagen N.V. mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Qiagen N.V. Recent Developments and Future Plans
- 2.7 Promega
- 2.7.1 Promega Details
- 2.7.2 Promega Major Business
- 2.7.3 Promega mRNA Vaccine Core Enzyme Product and Solutions
- 2.7.4 Promega mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Promega Recent Developments and Future Plans
- 2.8 Roche CustomBiotech
- 2.8.1 Roche CustomBiotech Details
- 2.8.2 Roche CustomBiotech Major Business
- 2.8.3 Roche CustomBiotech mRNA Vaccine Core Enzyme Product and Solutions
- 2.8.4 Roche CustomBiotech mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Roche CustomBiotech Recent Developments and Future Plans
- 2.9 Takara Bio Inc.
- 2.9.1 Takara Bio Inc. Details
- 2.9.2 Takara Bio Inc. Major Business
- 2.9.3 Takara Bio Inc. mRNA Vaccine Core Enzyme Product and Solutions
- 2.9.4 Takara Bio Inc. mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Takara Bio Inc. Recent Developments and Future Plans
- 2.10 Novoprotein
- 2.10.1 Novoprotein Details
- 2.10.2 Novoprotein Major Business
- 2.10.3 Novoprotein mRNA Vaccine Core Enzyme Product and Solutions
- 2.10.4 Novoprotein mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Novoprotein Recent Developments and Future Plans
- 2.11 Vazyme
- 2.11.1 Vazyme Details
- 2.11.2 Vazyme Major Business
- 2.11.3 Vazyme mRNA Vaccine Core Enzyme Product and Solutions
- 2.11.4 Vazyme mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 Vazyme Recent Developments and Future Plans
- 2.12 Hongene Biotech Corporatio
- 2.12.1 Hongene Biotech Corporatio Details
- 2.12.2 Hongene Biotech Corporatio Major Business
- 2.12.3 Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Product and Solutions
- 2.12.4 Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
- 2.12.5 Hongene Biotech Corporatio Recent Developments and Future Plans
- 2.13 Yeasen Biotechnology
- 2.13.1 Yeasen Biotechnology Details
- 2.13.2 Yeasen Biotechnology Major Business
- 2.13.3 Yeasen Biotechnology mRNA Vaccine Core Enzyme Product and Solutions
- 2.13.4 Yeasen Biotechnology mRNA Vaccine Core Enzyme Revenue, Gross Margin and Market Share (2018-2023)
- 2.13.5 Yeasen Biotechnology Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global mRNA Vaccine Core Enzyme Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of mRNA Vaccine Core Enzyme by Company Revenue
- 3.2.2 Top 3 mRNA Vaccine Core Enzyme Players Market Share in 2022
- 3.2.3 Top 6 mRNA Vaccine Core Enzyme Players Market Share in 2022
- 3.3 mRNA Vaccine Core Enzyme Market: Overall Company Footprint Analysis
- 3.3.1 mRNA Vaccine Core Enzyme Market: Region Footprint
- 3.3.2 mRNA Vaccine Core Enzyme Market: Company Product Type Footprint
- 3.3.3 mRNA Vaccine Core Enzyme Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Enzyme Type
- 4.1 Global mRNA Vaccine Core Enzyme Consumption Value and Market Share by Enzyme Type (2018-2023)
- 4.2 Global mRNA Vaccine Core Enzyme Market Forecast by Enzyme Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global mRNA Vaccine Core Enzyme Consumption Value Market Share by Application (2018-2023)
- 5.2 Global mRNA Vaccine Core Enzyme Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type (2018-2029)
- 6.2 North America mRNA Vaccine Core Enzyme Consumption Value by Application (2018-2029)
- 6.3 North America mRNA Vaccine Core Enzyme Market Size by Country
- 6.3.1 North America mRNA Vaccine Core Enzyme Consumption Value by Country (2018-2029)
- 6.3.2 United States mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
- 6.3.3 Canada mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
- 6.3.4 Mexico mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type (2018-2029)
- 7.2 Europe mRNA Vaccine Core Enzyme Consumption Value by Application (2018-2029)
- 7.3 Europe mRNA Vaccine Core Enzyme Market Size by Country
- 7.3.1 Europe mRNA Vaccine Core Enzyme Consumption Value by Country (2018-2029)
- 7.3.2 Germany mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
- 7.3.3 France mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
- 7.3.5 Russia mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
- 7.3.6 Italy mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type (2018-2029)
- 8.2 Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific mRNA Vaccine Core Enzyme Market Size by Region
- 8.3.1 Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value by Region (2018-2029)
- 8.3.2 China mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
- 8.3.3 Japan mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
- 8.3.4 South Korea mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
- 8.3.5 India mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
- 8.3.7 Australia mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type (2018-2029)
- 9.2 South America mRNA Vaccine Core Enzyme Consumption Value by Application (2018-2029)
- 9.3 South America mRNA Vaccine Core Enzyme Market Size by Country
- 9.3.1 South America mRNA Vaccine Core Enzyme Consumption Value by Country (2018-2029)
- 9.3.2 Brazil mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
- 9.3.3 Argentina mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type (2018-2029)
- 10.2 Middle East & Africa mRNA Vaccine Core Enzyme Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa mRNA Vaccine Core Enzyme Market Size by Country
- 10.3.1 Middle East & Africa mRNA Vaccine Core Enzyme Consumption Value by Country (2018-2029)
- 10.3.2 Turkey mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
- 10.3.4 UAE mRNA Vaccine Core Enzyme Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 mRNA Vaccine Core Enzyme Market Drivers
- 11.2 mRNA Vaccine Core Enzyme Market Restraints
- 11.3 mRNA Vaccine Core Enzyme Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 mRNA Vaccine Core Enzyme Industry Chain
- 12.2 mRNA Vaccine Core Enzyme Upstream Analysis
- 12.3 mRNA Vaccine Core Enzyme Midstream Analysis
- 12.4 mRNA Vaccine Core Enzyme Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on mRNA Vaccine Core Enzyme. Industry analysis & Market Report on mRNA Vaccine Core Enzyme is a syndicated market report, published as Global mRNA Vaccine Core Enzyme Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of mRNA Vaccine Core Enzyme market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
